H3Q5dop
H3Q5dop (or H3Q5-dopaminylation) is an epigenetic modification to the DNA packaging protein Histone H3 that indicates dopaminylation of the glutamine residue at position 5 (Gln5 or Q5).
≈ 5 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
H3Q5dop (or H3Q5-dopaminylation) is an epigenetic modification to the DNA packaging protein Histone H3 that indicates dopaminylation of the glutamine residue at position 5 (Gln5 or Q5). In general, monoaminylation refers to the overall class of post-translational modifications involving monoamines; however, these reactions are further classified by the individual monoamine reactant they describe (i.e., dopaminylation, serotonylation, histaminylation).
To date, histone H3 is the only histone protein known to undergo dopaminylation modifications, which have only been reported for glutamine position 5 (Gln5) of histone H3 (hereafter referred to as H3Q5dop). As such, histone dopaminylation currently refers to the covalent addition of dopamine to glutamine at position 5 (Gln5) of histone H3.
Histone monoaminylation modifications (i.e., H3Q5-dopaminylation, H3Q5-serotonylation, H3Q5-histaminylation) are associated with a number of regulatory effects, no two of which appear to be the same. H3Q5dop in particular has remained a seldom explored topic since its discovery in 2020.
Nevertheless, H3Q5dop has been reported in dopaminergic neurons of the nucleus accumbens (NAc), ventral tegmental area (VTA), and amygdala.…
H3Q5dop (or H3Q5-dopaminylation) is an epigenetic modification to the DNA packaging protein Histone H3 that indicates dopaminylation of the glutamine residue at position 5 (Gln5 or Q5). In general, monoaminylation refers to the overall class of post-translational modifications involving monoamines; however, these reactions are further classified by the individual monoamine reactant they describe (i.e., dopaminylation, serotonylation, histaminylation).
To date, histone H3 is the only histone protein known to undergo dopaminylation modifications, which have only been reported for glutamine position 5 (Gln5) of histone H3 (hereafter referred to as H3Q5dop). As such, histone dopaminylation currently refers to the covalent addition of dopamine to glutamine at position 5 (Gln5) of histone H3.
Histone monoaminylation modifications (i.e., H3Q5-dopaminylation, H3Q5-serotonylation, H3Q5-histaminylation) are associated with a number of regulatory effects, no two of which appear to be the same. H3Q5dop in particular has remained a seldom explored topic since its discovery in 2020.
Nevertheless, H3Q5dop has been reported in dopaminergic neurons of the nucleus accumbens (NAc), ventral tegmental area (VTA), and amygdala. H3Q5-dopaminylation has been implicated in a variety of processes, including cocaine-induced transcriptional plasticity, heroin-induced transcriptional and behavioral plasticity, and drug-induced transcriptional and behavioral changes.
Alongside H3Q5dop, the H3K4me3Q5dop modification has also been identified. Dopaminylation is known to influence both drug-seeking behaviors (i.e., cocaine, heroin) and differential gene expression programs associated with substance abuse, and has been associated with changes in epigenetic signatures within the limbic system following early-life stressful social experience (SSE) in rats.
Fig. 1 Mechanism for Histone Dopaminylation Dopaminylation is a two step, Ca 2+ -dependent reaction in which TGM2 catalyzes the covalent attachment of dopamine onto a glutamine residue (Gln5) of Histone H3. (A) The catalytic cysteine residue (Cys277) of TGM2 facilitates an initial acyl transfer reaction, which is ultimately followed by isopeptide bond formation (B). When intracellular Ca 2+ and dopamine concentrations are sufficient, TGM2-catalyzed dopaminylation of histone H3 can occur.
First, the catalytic cysteine residue (Cys277) in the TGM2 active site nucleophilically attacks the 𝛾-carboxamido group of the glutamine residue in an acyl transfer reaction (Fig. 1A), forming a thioester intermediate and releasing one molecule of ammonia (NH 3 ) as a result. Next, the deprotonated primary amine of the dopamine substrate nucleophilically attacks the 𝛾-thioester group of the intermediate, forming a stable isopeptide bond and ultimately releasing the enzyme (Fig. 1B). Monoaminylation Tissue Modification Biological Function References Dopaminylation Nucleus Accumbens (NAc) H3Q5dop Promotes cocaine-seeking behavior and regulates cocaine-induced gene expression programs (Stewart et al., 2023) Dopaminylation Ventral Tegmental Area (VTA) H3Q5dop Promotes heroin-seeking behavior and regulates gene expression programs associated with heroin abstinence (Fulton et al., 2022) Dopaminylation Amygdala H3Q5dop Modification was identified following early-life stressful social experience (SSE) in rat pups (Rajan et al., 2023) Dopaminylation Ventral Tegmental Area (VTA) H3Q5dop H3K4me3Q5dop Promotes relapse-like behavior and modulates neuronal gene expression patterns in the VTA following cocaine consumption (Lepack et al., 2020) In a study on the limbic system, low levels of trimethylation and dopaminylation of histone H3 at lysine position 4 (H3K4) and glutamine position 5 (H3Q5) in the amygdala led to failure in novel odor recognition for rat pups undergoing novel odor preference testing.
However, the authors of this study omit whether such modifications were in fact detected concurrently (i.e., H3K4me3Q5dop). Nevertheless, scent recognition testing serves as a critical methodology for evaluating memory, cognitive function, and sensory perception in rodent models, and thus represents an important mechanism for evaluating changes in neurotransmission and epigenetic regulation in response to environmental conditions such as stress.
Herein, failure to recognize novel odor was reportedly linked to increased dopamine transmission, decreased levels of TGM2, and increased histone trimethylation (H3K4me3) and dopaminylation (H3Q5dop) in the amygdala following exposure to early-life stressful social experience (SSE). It remains unclear whether the reported fluctuations in TGM2 levels could be attributed to changes in TGM2 expression levels or changes in TGM2 activity levels.
Ambiguity aside, this data provides useful insight, as early-life adversity paradigms appear sufficient for reconfiguration of epigenetic signatures within the limbic system, thereby establishing stable, differential epigenetic programs which may contribute to lifelong susceptibility for affective psychopathologies (i.e., major depressive disorder, bipolar disorder, anxiety disorders).
Text derived from https://en.wikipedia.org/w/index.php?oldid=1373753464 under CC BY-SA 4.0; modifications have been made.